Related references
Note: Only part of the references are listed.Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic Review
Massimo Radin et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
Beyond thrombosis: Anti-beta 2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome
Cecilia Beatrice Chighizola et al.
JOURNAL OF AUTOIMMUNITY (2018)
The treatment of anti-phospholipid syndrome: A comprehensive clinical approach
Cecilia Beatrice Chighizola et al.
JOURNAL OF AUTOIMMUNITY (2018)
Therapy for antiphospholipid miscarriages: Throwing the baby out with the bathwater?
Cecilia Beatrice Chighizola et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2018)
Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies
Zola Chihombori Quao et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2018)
Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study
Mara Taraborelli et al.
JOURNAL OF RHEUMATOLOGY (2017)
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances
Savino Sciascia et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome
Teresa Iwaniec et al.
THROMBOSIS RESEARCH (2017)
Does APS Impact Women's Fertility?
Cecilia Beatrice Chighizola et al.
CURRENT RHEUMATOLOGY REPORTS (2017)
Antiphospholipid Syndrome and Pregnancy Pathogenesis to Translation
Vikki M. Abrahams et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Activated signature of antiphospholipid syndrome neutrophils reveals potential therapeutic target
Jason S. Knight et al.
JCI INSIGHT (2017)
Antiphospholipid syndrome: an update for clinicians and scientists
Andrew P. Vreede et al.
CURRENT OPINION IN RHEUMATOLOGY (2017)
Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study
Arsene Mekinian et al.
AUTOIMMUNITY REVIEWS (2017)
Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery
Pier Luigi Meroni et al.
BLOOD (2016)
APS - Diagnostics and challenges for the future
V. Pengo et al.
AUTOIMMUNITY REVIEWS (2016)
Role of anti-domain 1-β2glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome
A. -S. De Craemer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Anti-beta-2 glycoprotein I epitope specificity: from experimental models to diagnostic tools
P. L. Meroni
LUPUS (2016)
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases
Jaume Alijotas-Reig et al.
AUTOIMMUNITY REVIEWS (2015)
Histopathology in the placentae of women with antiphospholipid antibodies: A systematic review of the literature
Chez A. Viall et al.
AUTOIMMUNITY REVIEWS (2015)
Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies
Shachaf Ofer-Shiber et al.
BLOOD COAGULATION & FIBRINOLYSIS (2015)
Update on the pathogenesis and treatment of the antiphospholipid syndrome
Cecilia Beatrice Chighizola et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study
Stephane Zuily et al.
RHEUMATOLOGY (2015)
Antiphospholipid Syndrome-Not a Noninflammatory Disease
Philip G. de Groot et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2-Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti-Domain 1 to Anti-Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome
Laura Andreoli et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Purified IgG from Patients with Obstetric but not IgG from Non-obstetric Antiphospholipid Syndrome Inhibit Trophoblast Invasion
Katie Poulton et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2015)
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R. Cervera et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
The global anti-phospholipid syndrome score in primary APS
Savino Sciascia et al.
RHEUMATOLOGY (2015)
A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients
Doruk Erkan et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder
Silvia D'Ippolito et al.
AUTOIMMUNITY REVIEWS (2014)
A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome
Chiara Agostinis et al.
BLOOD (2014)
Thrombotic risk assessment in APS: the Global APS Score (GAPSS)
S. Sciascia et al.
LUPUS (2014)
Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity
Amelia Ruffatti et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers
Pier Luigi Meroni et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Anti-β2GPI/β2GPI induced TF and TNF-α expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways
Hongxiang Xie et al.
MOLECULAR IMMUNOLOGY (2013)
Diagnosis of antiphospholipid syndrome in routine clinical practice
C. Gardiner et al.
LUPUS (2013)
The Pathogenesis of the Antiphospholipid Syndrome
Bill Giannakopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events
Kotaro Otomo et al.
ARTHRITIS AND RHEUMATISM (2012)
Anti-phospholipid induced murine fetal loss: Novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss
Yeny Martinez de la Torre et al.
JOURNAL OF AUTOIMMUNITY (2012)
Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels
Arsene Mekinian et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2012)
C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies
A. L. Carrera-Marin et al.
LUPUS (2012)
Interactions between coagulation and complement-their role in inflammation
Katerina Oikonomopoulou et al.
SEMINARS IN IMMUNOPATHOLOGY (2012)
Anti-β2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile?
Laura Andreoli et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Novel Assays of Thrombogenic Pathogenicity in the Antiphospholipid Syndrome Based on the Detection of Molecular Oxidative Modification of the Major Autoantigen β2-Glycoprotein I
Yiannis Ioannou et al.
ARTHRITIS AND RHEUMATISM (2011)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions
Chiara Agostinis et al.
BLOOD (2011)
First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss
Kate Bramham et al.
BLOOD (2011)
Pathogenesis of antiphospholipid syndrome: understanding the antibodies
Pier Luigi Meroni et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Differential Expression of Protease-Activated Receptors in Monocytes From Patients With Primary Antiphospholipid Syndrome
Chary Lopez-Pedrera et al.
ARTHRITIS AND RHEUMATISM (2010)
Beta 2 glycoprotein I is a substrate of thiol oxidoreductases
Freda H. Passam et al.
BLOOD (2010)
Naturally occurring free thiols within β2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury
Yiannis Ioannou et al.
BLOOD (2010)
Patients with antiphospholipid syndrome display endothelial perturbation
Massimo Cugno et al.
JOURNAL OF AUTOIMMUNITY (2010)
Effects of Polyclonal IgG Derived from Patients with Different Clinical Types of the Antiphospholipid Syndrome on Monocyte Signaling Pathways
Anastasia Lambrianides et al.
JOURNAL OF IMMUNOLOGY (2010)
Antiphospholipid syndrome
Guillermo Ruiz-Irastorza et al.
LANCET (2010)
Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification
A. Ruffatti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Antiphospholipid antibodies and the antiphospholipid syndrome: Pathogenic mechanisms
Silvia S. Pierangeli et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2008)
Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome
M. J. Cuadrado et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
Guillermina Girardi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappa B/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway
C Lopez-Pedrera et al.
ARTHRITIS AND RHEUMATISM (2006)
A peptide that mimics the Vth region of beta(2)glycoprotein I reverses antiphospholipid-mediated thrombosis in mice
M. Vega Ostertag et al.
LUPUS (2006)
Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor
F Fischetti et al.
BLOOD (2005)
TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss
J Berman et al.
JOURNAL OF IMMUNOLOGY (2005)
Histologic features of placentas and abortion specimens from women with anti phospholipid and antiphospholipid-like syndromes
JT Van Horn et al.
PLACENTA (2004)
Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation
G Girardi et al.
NATURE MEDICINE (2004)
Share Paper
